AU2012246490A1 — Therapeutic agent for tumor
Assigned to Eisai R&D Management Co Ltd · Expires 2013-08-01 · 13y expired
What this patent protects
A therapeutic agent for tumor, comprising a combination of a compound represented by formula (I) or a pharmacologically acceptable salt thereof and a compound represented by formula (II). The therapeutic agent has a significant anti-tumor effect compared with that achieved when e…
USPTO Abstract
A therapeutic agent for tumor, comprising a combination of a compound represented by formula (I) or a pharmacologically acceptable salt thereof and a compound represented by formula (II). The therapeutic agent has a significant anti-tumor effect compared with that achieved when each of the compounds is used singly. [In the formulae, R
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.